
LNTH
USDLantheus Holdings Inc. Common Stock
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$103.760
Hoch
$103.810
Tief
$99.747
Volumen
0.13M
Unternehmensfundamentaldaten
Marktkapitalisierung
7.1B
Branche
Drug Manufacturers - Specialty & Generic
Land
United States
Handelsstatistiken
Durchschnittliches Volumen
0.90M
Börse
NGM
Währung
USD
52-Wochen-Spanne
KI-Analysebericht
Zuletzt aktualisiert: 26. Apr. 2025LNTH (Lantheus Holdings Inc. Common Stock): Analyzing Recent Moves & What Might Come Next
Stock Symbol: LNTH Generate Date: 2025-04-26 15:10:16
Alright, let's break down what's been happening with Lantheus stock and what the data we have might suggest. Think of this as looking under the hood to see what makes it tick right now.
Recent News Buzz: What's the Vibe?
The main piece of news we've got is pretty straightforward: Lantheus is holding its first-quarter earnings call on May 7th. This isn't news that tells us if they did well or poorly yet; it's just the announcement of when they'll tell us. It's a heads-up for investors to tune in.
Now, while this specific announcement is neutral, the recommendation data provided mentions that recent news sentiment overall has been "highly positive." This suggests that other news or general market chatter around Lantheus lately has been good, creating some positive energy around the stock leading up to this earnings report.
Price Check: What's the Stock Been Doing?
Looking back over the last few months, this stock has seen some action. It started the year around the high $90s, took a dip down into the low $80s in February, but then staged a pretty strong comeback, climbing back up and even hitting over $110 in March.
More recently, in April, the price has settled down a bit from that peak. It's been trading roughly between $95 and $104. The current price is sitting right around the $101-$103 mark. So, after that big run-up and slight pullback, it seems to be consolidating or maybe starting to edge up again.
The AI prediction for the very near term (today and the next two days) suggests a positive move, forecasting a small gain today (0.00%, essentially flat) followed by increases of around 2.8% and 3.7% over the next couple of days. This aligns with the idea that the stock might be looking to climb a bit from its current level.
Putting It Together: Outlook & Ideas
Based on the combination of factors – the upcoming, potentially market-moving earnings call, the indication of positive sentiment from other recent news, the stock's recent price recovery and current stability, and the AI's short-term positive forecast – the situation seems to lean slightly positive for the near term.
Here's the thing: The earnings call on May 7th is a big wildcard. Good results could send the stock higher, while disappointing ones could cause a drop. But leading up to it, the data suggests some positive momentum might be building.
- Potential Entry Consideration: If you were considering getting in, the recommendation data points to potential entry areas around $103.09 and $103.71. The current price is right in this neighborhood. This area could be one to watch if you think the positive sentiment and AI prediction have legs before the earnings report.
- Potential Exit/Stop-Loss Consideration: To manage risk, the recommendation data suggests a stop-loss level around $93.27. This is below the recent trading range and could be a point to consider exiting if the stock turns south unexpectedly. For potential gains, the recommendation data suggests a take-profit level around $110.58. This is close to the recent March peak and could be a target if the stock rallies.
Remember, these are just potential levels based on the provided data and analysis, not guarantees.
Company Context
Just a quick note on what Lantheus actually does: They're in the healthcare sector, specifically making diagnostic and therapeutic products. Think things that help doctors see what's going on inside the body (like imaging agents for cancer or heart issues) and some treatments too. They're also dabbling in AI tools for analyzing medical images. This means news about their specific products, clinical trials, or sales figures (which we'll hear about in the earnings call) are really important drivers for the stock price.
Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research or consult with a qualified financial advisor before making any investment decisions.
Ähnliche Nachrichten
Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time
BEDFORD, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the "Company") (NASDAQ:LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, May 7, 2025, to
KI-VorhersageBeta
KI-Empfehlung
Aktualisiert am: 28. Apr. 2025, 11:04
73.3% Konfidenz
Risiko & Handel
Einstiegspunkt
$101.33
Gewinnmitnahme
$108.49
Stop-Loss
$91.59
Schlüsselfaktoren
Ähnliche Aktien

EMP
Entergy Mississippi LLC First Mortgage Bonds 4.90% Series Due October 1 2066

MCRI
Monarch Casino & Resort Inc.

SHO
Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc. Common Shares

DENN
Denny's Corporation

EPRX
Eupraxia Pharmaceuticals Inc.
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.